betnesol n
glaxosmithkline nz limited - betamethasone sodium phosphate 0.1%{relative} (0.105% including 10% manufacturers overage.); neomycin sulfate 0.5%{relative} (0.55% incl. 10% overage. equiv. to 0.385%w/v neomycin base.); - ear/eye drops - active: betamethasone sodium phosphate 0.1%{relative} (0.105% including 10% manufacturers overage.) neomycin sulfate 0.5%{relative} (0.55% incl. 10% overage. equiv. to 0.385%w/v neomycin base.) excipient: benzalkonium chloride dibasic sodium phosphate disodium edetate dihydrate macrogol 300 monobasic sodium phosphate dihydrate phosphoric acid purified water sodium formate sodium hydroxide sodium sulfate
betnesol -n eye drop
betamethasone sodium phosphate 0.1% neomycin sulphate 0.5%
betnesol pellets 0.1mg tablet
glaxo canada inc - betamethasone sodium phosphate - tablet - 0.1mg - betamethasone sodium phosphate 0.1mg - corticosteroids
betnesol retention enemas
glaxo canada inc - betamethasone sodium phosphate - enema - 5mg - betamethasone sodium phosphate 5mg - anti-inflammatory agents
betnesol tab 0.5mg tablet
glaxo canada inc - betamethasone sodium phosphate - tablet - .5mg - betamethasone sodium phosphate .5mg - adrenals
betnesol eye and ear drops
glaxo canada inc - betamethasone sodium phosphate - drops - .1% - betamethasone sodium phosphate .1% - anti-inflammatory agents
betnesol tablets tablet (effervescent)
shire pharma canada ulc - betamethasone (betamethasone sodium phosphate) - tablet (effervescent) - 0.5mg - betamethasone (betamethasone sodium phosphate) 0.5mg - adrenals
betnesol eye and ear drops 0.1% liquid
shire pharma canada ulc - betamethasone sodium phosphate - liquid - 0.1% - betamethasone sodium phosphate 0.1% - anti-inflammatory agents
betnesol 0.1% eye/ear/nose drops
rph pharmaceuticals ab - betamethasone sodium phosphate - ear/eye/nose drops solution - 1mg/1ml
betnesol 500microgram soluble tablets
focus pharmaceuticals ltd - betamethasone sodium phosphate - soluble tablet - 500microgram